rivotril 0.5 mg
cheplapharm arzneimittel gmbh - klonazepam - tablett - 0.5 mg
rivotril 2 mg
cheplapharm arzneimittel gmbh - klonazepam - tablett - 2 mg
symtuza
janssen-cilag international nv - darunavir, cobicistat, emtricitabine, tenofovir alafenamide - hiv-infeksjoner - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - symtuza er indisert for behandling av infeksjon av human immunodeficiency virus type 1 (hiv-1) hos voksne og ungdom (i alderen 12 år og eldre med kroppsvekt minst 40 kg). genotypic testing should guide the use of symtuza.
sabrilex 500 mg
sanofi-aventis norge (3) - vigabatrin - tablett, filmdrasjert - 500 mg
sabrilex 500 mg
sanofi-aventis norge (3) - vigabatrin - granulat til mikstur, oppløsning - 500 mg
taloxa 600 mg
n.v. organon - kloosterstraat - felbamat - tablett - 600 mg
xtandi
astellas pharma europe b.v. - enzalutamide - prostata neoplasmer - endokrin terapi - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
orfiril 300 mg
desitin arzneimittel gmbh - natriumvalproat - enterotablett - 300 mg
orfiril long 500 mg
desitin arzneimittel gmbh - natriumvalproat - depotgranulat - 500 mg